0000939767-15-000091.txt : 20151014
0000939767-15-000091.hdr.sgml : 20151014
20151014170508
ACCESSION NUMBER: 0000939767-15-000091
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151012
FILED AS OF DATE: 20151014
DATE AS OF CHANGE: 20151014
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EXELIXIS, INC.
CENTRAL INDEX KEY: 0000939767
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 043257395
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0102
BUSINESS ADDRESS:
STREET 1: 210 E. GRAND AVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 6508377000
MAIL ADDRESS:
STREET 1: 210 E. GRAND AVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: EXELIXIS INC
DATE OF NAME CHANGE: 20000207
FORMER COMPANY:
FORMER CONFORMED NAME: EXELIXIS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20000106
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lamb Peter
CENTRAL INDEX KEY: 0001387306
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30235
FILM NUMBER: 151158593
MAIL ADDRESS:
STREET 1: PO BOX 511, 170 HARBOR WAY
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94083-0511
4
1
wf-form4_144485669542135.xml
FORM 4
X0306
4
2015-10-12
0
0000939767
EXELIXIS, INC.
EXEL
0001387306
Lamb Peter
C/O EXELIXIS, INC.
210 E. GRAND AVE.
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
EVP, Discovery Research & CSO
Common Stock
2015-10-12
4
M
0
525
5.63
A
36998
D
Common Stock
2015-10-12
4
M
0
1400
5.63
A
38398
D
Common Stock
2015-10-12
4
M
0
2500
5.63
A
40898
D
Common Stock
2015-10-12
4
M
0
8000
5.63
A
48898
D
Common Stock
2015-10-12
4
M
0
20000
5.63
A
68898
D
Common Stock
2015-10-12
4
M
0
28000
5.63
A
96898
D
Common Stock
2015-10-12
4
M
0
84000
5.63
A
180898
D
Common Stock
2015-10-12
4
M
0
19333
5.63
A
200231
D
Common Stock
2015-10-12
4
M
0
39999
5.63
A
240230
D
Common Stock
2015-10-12
4
M
0
39583
5.63
A
279813
D
Common Stock
2015-10-12
4
M
0
56936
5.63
A
336749
D
Common Stock
2015-10-12
4
S
0
300276
5.839
D
36473
D
Common Stock
2015-10-13
4
M
0
600
5.63
A
37073
D
Common Stock
2015-10-13
4
S
0
600
5.80
D
36473
D
Common Stock
14478
I
By 401(k)
Option (right to buy)
5.63
2015-10-12
4
M
0
525
0
D
2010-08-05
2015-10-17
Common Stock
525.0
242815
D
Option (right to buy)
5.63
2015-10-12
4
M
0
1400
0
D
2010-08-05
2015-10-17
Common Stock
1400.0
241415
D
Option (right to buy)
5.63
2015-10-12
4
M
0
2500
0
D
2010-08-05
2015-10-17
Common Stock
2500.0
238915
D
Option (right to buy)
5.63
2015-10-12
4
M
0
8000
0
D
2010-08-05
2015-10-17
Common Stock
8000.0
230915
D
Option (right to buy)
5.63
2015-10-12
4
M
0
20000
0
D
2010-08-05
2015-10-17
Common Stock
20000.0
210915
D
Option (right to buy)
5.63
2015-10-12
4
M
0
28000
0
D
2010-08-05
2015-10-17
Common Stock
28000.0
182915
D
Option (right to buy)
5.63
2015-10-12
4
M
0
84000
0
D
2010-08-05
2015-10-17
Common Stock
84000.0
98915
D
Option (right to buy)
5.63
2015-10-12
4
M
0
19333
0
D
2010-08-05
2015-10-17
Common Stock
19333.0
79582
D
Option (right to buy)
5.63
2015-10-12
4
M
0
39999
0
D
2010-08-05
2015-10-17
Common Stock
39999.0
39583
D
Option (right to buy)
5.63
2015-10-12
4
M
0
39583
0
D
2010-08-05
2015-10-17
Common Stock
39583.0
0
D
Option (right to buy)
5.63
2015-10-12
4
M
0
56936
0
D
2010-08-05
2015-10-17
Common Stock
56936.0
52149
D
Option (right to buy)
5.63
2015-10-13
4
M
0
600
0
D
2010-08-05
2015-10-17
Common Stock
600.0
51549
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.80 to $6.00, inclusive. The reporting person undertakes to provide to Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Represents 14,478 shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of October 13, 2015.
Option granted pursuant to Issuer's 2000 Equity Incentive Plan. One hundred percent (100%) of the shares vest one year from date of grant.
Option granted pursuant to Issuer's 2000 Equity Incentive Plan. Thirty-three percent (33%) of the shares vest one year from date of grant, and the remaining shares vest in 24 equal monthly installments thereafter.
/s/ Jeffrey J. Hessekiel, Attorney in Fact
2015-10-13